Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders.
The use of dilute (1/10%) sodium hyaluronate (Healon) eyedrops has given definite subjective patient improvement in a variety of ocular surface disorders, especially keratitis sicca. No adverse effects of the sodium hyaluronate drops have been encountered in patients who have used the drops for as long as two years. Masked trials and objective improvement of corneal staining patterns have also confirmed its efficacy.
D003261:Contact Lenses / Q000009:adverse effects; D003316:Corneal Diseases / Q000188:drug therapy*; D003317:Corneal Dystrophies, Hereditary / Q000188:drug therapy; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D007634:Keratitis / Q000188:drug therapy; D009883:Ophthalmic Solutions
D009883:Ophthalmic Solutions; D006820:Hyaluronic Acid